Trump Opens the Door for Psychedelic Drugs to Treat Serious Mental Illness
President Donald Trump has opened the door for psychedelic drugs to be used as a potential treatment for serious mental illness. He signed an executive order on 18 April 2026 that empowers the FDA to do this and put aside US$50 million for psychedelics research.
The Big Cannabis Issue Facing the World: Who Benefits from Legalization and Who Gets Left Behind?
International collaboration is one of the pathways for marginalized cannabis communities to have their voices heard. Soweto Cannabis Association founder Tia Ramfate (pictured here) is to visit Canada to strengthen international ties for the AfuRaka Foundation she has launched.
Ninth Wave’s Campher: Cannabis ‘Grey Zone Regulation will Lead to Demand for Marketing and Sales Jobs
As the cannabis retail ‘Grey Zone’ becomes regulated there will be a growing demand for sales and marketing skills sets within the sector. Ninth Wave recruitment specialist Lourie Campher (pictured here) says cultivation and pharmaceutical specialists are currently in demand, but the job pool is steadily expanding into other disciplines.